Malaria Vaccines are used for malaria treatment.Malaria is a severe and widespread disease caused by a parasitic infection by protozoan Plasmodium when transmitted by various species of anopheles mosquitoes.

The growing incidence of malaria globally and major players pledging for low profit margin over vaccines is expected to boost growth of the market for malaria vaccines market.

The global Malaria Vaccines market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025.
This report focuses on Malaria Vaccines volume and value at global level, regional level and company level. From a global perspective, this report represents overall Malaria Vaccines market size by analyzing historical data and future prospect.
Regionally, this report categorizes the production, apparent consumption, export and import of Malaria Vaccines in North America, Europe, China, Japan, Southeast Asia and India.
For each manufacturer covered, this report analyzes their Malaria Vaccines manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.

The following manufacturers are covered:
GlaxoSmithKline plc
Sanaria Inc
Nobelpharma Co
Sumaya Biotech
GenVec
...

Segment by Regions
North America
Europe
China
Japan
Southeast Asia
India

Segment by Type
Pre-Erythrocytic Vaccine
Erythrocytic Vaccine
Multi-antigen Vaccine

Segment by Application
Hospitals
Clinics
Community Centers